We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$20.8B
AUM Growth
+$1.36B
Cap. Flow
-$242M
Cap. Flow %
-1.17%
Top 10 Hldgs %
41.79%
Holding
274
New
20
Increased
77
Reduced
99
Closed
5

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$27.7M
2
BKNG icon
Booking.com
BKNG
+$16.4M
3
AMZN icon
Amazon
AMZN
+$14.6M
4
BR icon
Broadridge
BR
+$12.5M
5
BX icon
Blackstone
BX
+$11.1M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.3M
2
MSFT icon
Microsoft
MSFT
+$18.7M
3
CB icon
Chubb
CB
+$16M
4
BUD icon
AB InBev
BUD
+$16M
5
JPM icon
JPMorgan Chase
JPM
+$15.7M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.04%
2 Financials 19.79%
3 Technology 15.34%
4 Energy 11.59%
5 Healthcare 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$640B
$304M 1.46%
2,084,022
+1,128
+0.1% +$153K
KMI icon
27
Kinder Morgan
KMI
$70.9B
$293M 1.41%
13,836,914
-115,333
-0.8% -$2.33M
MRK icon
28
Merck
MRK
$322B
$285M 1.37%
3,284,105
+29,361
+0.9% +$2.41M
ABBV icon
29
AbbVie
ABBV
$465B
$283M 1.36%
3,193,143
-95,360
-3% -$7.92M
EL icon
30
Estee Lauder
EL
$30.4B
$263M 1.27%
1,273,386
-22,368
-2% -$4.34M
AMZN icon
31
Amazon
AMZN
$2.44T
$258M 1.24%
2,792,780
+164,460
+6% +$14.6M
NVO
32
Novo Nordisk
NVO
$228B
$255M 1.23%
8,809,200
-230,448
-3% -$6.38M
BLK icon
33
Blackrock
BLK
$167B
$241M 1.16%
479,917
-15,271
-3% -$7.24M
EV
34
DELISTED
Eaton Vance Corp.
EV
$241M 1.16%
5,160,000
AXP icon
35
American Express
AXP
$224B
$227M 1.09%
1,821,254
-90,443
-5% -$10.8M
UNH icon
36
UnitedHealth
UNH
$382B
$210M 1.01%
713,314
-14,086
-2% -$3.69M
RTX icon
37
RTX Corp
RTX
$290B
$198M 0.96%
2,104,505
-8,571
-0.4% -$778K
LIN icon
38
Linde
LIN
$236B
$182M 0.88%
855,734
-32,316
-4% -$6.51M
APD icon
39
Air Products & Chemicals
APD
$65.5B
$167M 0.8%
709,002
-549
-0.1% -$124K
ADP icon
40
Automatic Data Processing
ADP
$109B
$163M 0.79%
957,342
-31,469
-3% -$5.21M
COP icon
41
ConocoPhillips
COP
$144B
$160M 0.77%
2,455,823
-39,672
-2% -$2.33M
CP icon
42
Canadian Pacific Kansas City
CP
$81B
$155M 0.75%
3,046,795
-83,450
-3% -$3.91M
ISRG icon
43
Intuitive Surgical
ISRG
$127B
$148M 0.71%
750,438
+17,862
+2% +$3.34M
ASML icon
44
ASML
ASML
$596B
$132M 0.64%
446,598
-33,293
-7% -$8.99M
WMT icon
45
Walmart Inc
WMT
$909B
$112M 0.54%
2,816,067
-92,451
-3% -$3.67M
NKE icon
46
Nike
NKE
$64.1B
$111M 0.53%
1,091,541
-50,222
-4% -$4.73M
MA icon
47
Mastercard
MA
$498B
$102M 0.49%
341,042
+9,987
+3% +$2.82M
ICE icon
48
Intercontinental Exchange
ICE
$87.2B
$100M 0.48%
1,083,608
-43,517
-4% -$4.04M
BRK.A icon
49
Berkshire Hathaway Class A
BRK.A
$1.1T
$97.5M 0.47%
287
+1
+0.3% +$326K
STT icon
50
State Street
STT
$48.4B
$96.5M 0.46%
1,220,359
-40,590
-3% -$2.86M

Similar funds

Fayez Sarofim & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Fayez Sarofim & Co held 274 positions worth $20.8B, up 7% from $19.4B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co's Q4 2019 filing shows 20 new, 77 increased, 99 reduced and 5 closed positions. Its largest new stake was Williams Companies: 62,000 shares worth $1.47M. The largest sale was Apple, an estimated $22.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • Fayez Sarofim & Co's largest Q4 2019 buy was Williams Companies: 62,000 shares worth $1.47M.
  • Fayez Sarofim & Co added most to Progressive in Q4 2019, an estimated $27.7M increase.
  • Fayez Sarofim & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $22.3M.
  • Fayez Sarofim & Co fully exited Charles Schwab in Q4 2019, selling an estimated $1.58M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $20.8B portfolio in Q4 2019.
  • Fayez Sarofim & Co opened 20 new positions and closed 5 in Q4 2019.
  • Fayez Sarofim & Co's portfolio value rose 7% quarter-over-quarter to $20.8B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2019, filed 14 Feb 2020.